-transparent.png){kind=logo}
OBJECTIVE To determine whether inhaled fluticasone propionate has long-term effects on growth in children with persistent asthma. METHODS In a double-blind, randomized, parallel-group, multicenter study, 325 prepubescent children with persistent asthma and normal growth rates were treated with placebo or inhaled fluticasone propionate powder 50 microg or 100 microg administered twice daily by a breath-actuated device for 1 year. Growth was evaluated monthly, whereas other safety variables and pulmonary function were evaluated periodically. RESULTS The prepubescent patients showed no statistically significant differences in mean height, mean growth velocity, or mean skeletal age between any of the treatment groups at any time. Over a period of 1 year, mean height (+/- SE) increased 6.15 +/- 0.17 cm in the placebo group, 5.94 +/- 0.16 cm in the fluticasone propionate 50 microg group, and 5.73 +/- 0.13 cm in the fluticasone propionate 100 microg group (p = 0.308, overall). CONCLUSIONS Prepubescent children treated with fluticasone propionate 50 microg and 100 microg administered twice daily for 1 year grew at rates similar to placebo-treated control subjects and at rates equal to expected growth velocity for age.
D B Allen, and
E A Bronsky, and
C F LaForce, and
R A Nathan, and
D G Tinkelman, and
M L Vandewalker, and
P Konig
July 1996,
Lancet (London, England),
D B Allen, and
E A Bronsky, and
C F LaForce, and
R A Nathan, and
D G Tinkelman, and
M L Vandewalker, and
P Konig
April 1996,
The Journal of family practice,
D B Allen, and
E A Bronsky, and
C F LaForce, and
R A Nathan, and
D G Tinkelman, and
M L Vandewalker, and
P Konig
March 1998,
Chest,
D B Allen, and
E A Bronsky, and
C F LaForce, and
R A Nathan, and
D G Tinkelman, and
M L Vandewalker, and
P Konig
October 1996,
American journal of respiratory and critical care medicine,
D B Allen, and
E A Bronsky, and
C F LaForce, and
R A Nathan, and
D G Tinkelman, and
M L Vandewalker, and
P Konig
January 1998,
Clinical therapeutics,
D B Allen, and
E A Bronsky, and
C F LaForce, and
R A Nathan, and
D G Tinkelman, and
M L Vandewalker, and
P Konig
October 1994,
The Journal of allergy and clinical immunology,
D B Allen, and
E A Bronsky, and
C F LaForce, and
R A Nathan, and
D G Tinkelman, and
M L Vandewalker, and
P Konig
December 2016,
The New England journal of medicine,
D B Allen, and
E A Bronsky, and
C F LaForce, and
R A Nathan, and
D G Tinkelman, and
M L Vandewalker, and
P Konig
December 2016,
The New England journal of medicine,
D B Allen, and
E A Bronsky, and
C F LaForce, and
R A Nathan, and
D G Tinkelman, and
M L Vandewalker, and
P Konig
April 2007,
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,
D B Allen, and
E A Bronsky, and
C F LaForce, and
R A Nathan, and
D G Tinkelman, and
M L Vandewalker, and
P Konig
January 2004,
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego,
